Citius Oncology, Inc. CTOR Change in AP
Change in AP at other companies
Other financials
Where this comes from
Reported directly by Citius Oncology, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsPayableTrade.
The official record: Citius Oncology, Inc.’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →
Ask your AI about Citius Oncology, Inc.'s change in ap.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Citius Oncology, Inc.'s change in AP?
- Citius Oncology, Inc. (CTOR) reported change in AP of -$1.56M in Q1 2026.
- How has Citius Oncology, Inc.'s change in AP changed year-over-year?
- Citius Oncology, Inc.'s change in AP decreased by 186.8% year-over-year, from $1.8M to -$1.56M.
- What is the long-term trend for Citius Oncology, Inc.'s change in AP?
- Over 2 years (2023 to 2025), Citius Oncology, Inc.'s change in AP has grown at a 182.1% compound annual growth rate (CAGR), from $1.2M to $9.52M.
- What does change in AP mean?
- Increase or decrease in amounts owed to suppliers — a key working capital component affecting operating cash flow.